LEPZACITINIB

UNII:	DQN3V3R84U
Type:	INGREDIENT SUBSTANCE
Formula:	C₁₈H₂₁N₅O₃
Preferred Substance Name:	LEPZACITINIB
InChIKey:	QQOPOYMFJLUSBI-GFCCVEGCSA-N
GSRS Full Record:	DQN3V3R84U i

2321488-47-3
1H-Pyrrolo[2,3-b]pyridine-5-carboxylic acid, 4-[[(3R)-1-(2-cyanoacetyl)-3-piperidinyl]amino]-, ethyl ester
ATI-1777
ATI1777
Ethyl (3R)-4-((1-(2-cyanoacetyl)piperidin-3-yl)amino)-1H-pyrrolo[2,3-b]pyridine-5-carboxylate
Ethyl 4-{[(3R)-1-(cyanoacetyl)piperidin-3-yl]amino}-1Hpyrrolo[ 2,3-b]pyridine-5-carboxylate
LEPZACITINIB [USAN]
Lepzacitinib
Lepzacitinib [WHO-DD]
ethyl 4-[[(3R)-1-(2-cyanoacetyl)piperidin-3-yl]amino]-1H-pyrrolo[2,3-b]pyridine-5-carboxylate
lepzacitinib [INN]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

LEPZACITINIB

Synonyms and Mappings

Resources